XEN Glaucoma Treatment System

Implant, Eye Valve

Allergan, Inc.

The following data is part of a premarket notification filed by Allergan, Inc. with the FDA for Xen Glaucoma Treatment System.

Pre-market Notification Details

Device IDK161457
510k NumberK161457
Device Name:XEN Glaucoma Treatment System
ClassificationImplant, Eye Valve
Applicant Allergan, Inc. 26970 Aliso Viejo Parkway, Suite 200 Aliso Viejo,  CA  92656
ContactBarbara A. Niksch
CorrespondentBarbara A. Niksch
Allergan, Inc. 2525 Dupont Drive Mail Code T2-6L Irvine,  CA  92612
Product CodeKYF  
CFR Regulation Number886.3920 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2016-05-26
Decision Date2016-11-21
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
10888628032439 K161457 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.